Literature DB >> 6177865

Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen.

B C Strnad, T Schuster, R Klein, R F Hopkins, T Witmer, R H Neubauer, H Rabin.   

Abstract

Five murine hybridoma lines that produce monoclonal antibodies against Epstein-Barr virus membrane antigen (MA) were established. Immunoprecipitation experiments demonstrated that three of the antibodies precipitated both the 236,000 (236K) MA and the 212K MA. The other two antibodies precipitated the 86K MA. Antibodies against the 236K-212K MA and the 86K MA mediated complement-dependent cytolysis of Epstein-Barr-virus-infected cells. The antibodies against the 86K MA neutralized both the B95-8 and P3HR-1 viruses.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177865      PMCID: PMC256747          DOI: 10.1128/JVI.41.1.258-264.1982

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation.

Authors:  N Mueller-Lantzsch; N Yamamoto; H zur Hausen
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

2.  The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses.

Authors:  R C Nowinski; M E Lostrom; M R Tam; M R Stone; W N Burnette
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

3.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

4.  Biochemical identification of primate lymphoid cell-surface glycoproteins.

Authors:  B C Strnad; R H Neubauer; H Rabin
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

5.  Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril.

Authors:  M A Markwell; C F Fox
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

6.  External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes.

Authors:  C G Gahmberg; S I Hakomori
Journal:  J Biol Chem       Date:  1973-06-25       Impact factor: 5.157

7.  Different surface glycoprotein patterns on human T-, B- and leukemic-lymphocytes.

Authors:  L C Andersson; C Wasastjerna; C G Gahmberg
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

8.  Polypeptides of the Epstein-Barr virus membrane antigen complex.

Authors:  D A Thorley-Lawson; C M Edson
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

9.  Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.

Authors:  L F Qualtiere; G R Pearson
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  52 in total

1.  Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion.

Authors:  Austin N Kirschner; Jasmina Omerovic; Boris Popov; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

Review 3.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

4.  Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H.

Authors:  B G Klupp; W Fuchs; E Weiland; T C Mettenleiter
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 5.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.

Authors:  Austin N Kirschner; Amanda S Lowrey; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

7.  Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.

Authors:  R S Haddad; L M Hutt-Fletcher
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Functional homology of gHs and gLs from EBV-related gamma-herpesviruses for EBV-induced membrane fusion.

Authors:  Jasmina Omerović; Richard Longnecker
Journal:  Virology       Date:  2007-05-02       Impact factor: 3.616

9.  Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.

Authors:  X Wang; W J Kenyon; Q Li; J Müllberg; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein.

Authors:  J P Stewart; N J Janjua; S D Pepper; G Bennion; M Mackett; T Allen; A A Nash; J R Arrand
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.